Benicar
Product Images NDC 68151-4633

3 FDA label images from Carilion Materials Management · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Benicar (NDC 68151-4633). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Olmesartan Medoxomil (Benicar Figure 1)

Structural Formula For Olmesartan Medoxomil (Benicar Figure 1)
Chemical structure of the active ingredient for Benicar by Carilion Materials Management, showing a complex molecular diagram with multiple rings, carbons, nitrogens, and functional groups including a carboxyl group and a lactone ring.*
FDA Label Image

Benicar Dose Response: Placebo-adjusted Reduction In Blood Pressure (mm Hg) (Benicar Figure 2)

Benicar Dose Response: Placebo-adjusted Reduction In Blood Pressure (mm Hg) (Benicar Figure 2)
A dose-response line graph for Benicar showing placebo-adjusted reduction in blood pressure (mmHg). The graph plots Benicar dose (mg) on the x-axis against reduction in BP (mmHg) on the y-axis. Two lines represent systolic BP and diastolic BP reductions, indicating greater systolic reduction at increasing doses.*
FDA Label Image

Label Image (Lbl681514633)

Label Image (Lbl681514633)
Label for Benicar containing olmesartan medoxomil 5 mg tablets. Manufactured by Daiichi-Sankyo. Includes lot number 177698 and expiration date 07/14. Marked Rx only and displays a barcode with the number 0000004633.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.